{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:22:57Z","timestamp":1794565377091,"version":"4.9.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801817"],"award-info":[{"award-number":["81801817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["B25B200139"],"award-info":[{"award-number":["B25B200139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20525"],"award-info":[{"award-number":["U24A20525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20333"],"award-info":[{"award-number":["U22A20333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402501"],"award-info":[{"award-number":["82402501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925019"],"award-info":[{"award-number":["81925019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3810002"],"award-info":[{"award-number":["2023YFB3810002"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3810003"],"award-info":[{"award-number":["2023YFB3810003"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3810000"],"award-info":[{"award-number":["2023YFB3810000"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003815","name":"Huaqiao University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003815","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biomaterials.2026.124317","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:22:46Z","timestamp":1778944966000},"page":"124317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Regorafenib and R837 nanoparticle-stabilized Pickering emulsions overcome the angiogenesis-immune tolerance axis in transarterial chemoembolization"],"prefix":"10.1016","volume":"334","author":[{"given":"Yisheng","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-7286","authenticated-orcid":false,"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4251-0645","authenticated-orcid":false,"given":"Hongwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib1","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124317_bib2","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242315","article-title":"Idarubicin versus epirubicin in transarterial chemoembolization for Barcelona clinic liver cancer stage B hepatocellular carcinoma: an open-label, randomized, phase IV trial","volume":"315","author":"Liu","year":"2025","journal-title":"Radiology"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124317_bib3","doi-asserted-by":"crossref","first-page":"29047","DOI":"10.1021\/acsami.5c05525","article-title":"Micro-nano convergence-driven radiotheranostic revolution in hepatocellular carcinoma","volume":"17","author":"Peng","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124317_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2468-1253(24)00247-4","article-title":"Combination locoregional and systemic therapies in hepatocellular carcinoma","volume":"10","author":"Zhong","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124317_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10404","article-title":"An exploratory human study of superstable homogeneous lipiodol-indocyanine green formulation for precise surgical navigation in liver cancer","volume":"8","author":"He","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124317_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.952194","article-title":"A superstable homogeneous lipiodol-nanoformulation to overcome the dilemma of interventional embolization chemotherapy","volume":"10","author":"Peng","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124317_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.scib.2020.06.029","article-title":"Superstable homogeneous iodinated formulation technology: revolutionizing transcatheter arterial chemoembolization","volume":"65","author":"Cheng","year":"2020","journal-title":"Sci. Bull."},{"key":"10.1016\/j.biomaterials.2026.124317_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"Pt 1","key":"10.1016\/j.biomaterials.2026.124317_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcis.2021.08.179","article-title":"Improving regorafenib's organ target precision via nano-assembly to change its delivery mode abolishes chemoresistance and liver metastasis of colorectal cancer","volume":"607","author":"Liu","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.biomaterials.2026.124317_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123018","article-title":"Pickering emulsion with tumor vascular destruction and microenvironment modulation for transarterial embolization therapy","volume":"316","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124317_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410484","article-title":"Arginine-loaded nano-calcium-phosphate-stabilized lipiodol pickering emulsions potentiates transarterial embolization-immunotherapy","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124317_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410873","article-title":"A lipiodol pickering emulsion stabilized by iron-doped carbon nanozymes for liver transarterial chemoembolization","volume":"12","author":"Xia","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12951-023-02181-x","article-title":"Temperature sensitive nanogel-stabilized pickering emulsion of fluoroalkane for ultrasound guiding vascular embolization therapy","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.scib.2026.03.042","article-title":"Zinc nanomedicine sensitizes transarterial chemo-immuno-embolization for hepatocellular carcinoma","author":"Peng","year":"2026","journal-title":"Sci. Bull."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124317_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2025.01.088","article-title":"Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity","volume":"380","author":"Peng","year":"2025","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124317_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ctrv.2018.08.006","article-title":"Interventional therapy combined with immune checkpoint inhibitors: emerging opportunities for cancer treatment in the era of immunotherapy","volume":"74","author":"Chang","year":"2019","journal-title":"Cancer Treat Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124317_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jconrel.2022.09.009","article-title":"Tumor immunotherapy boosted by R837 nanocrystals through combining chemotherapy and mild hyperthermia","volume":"350","author":"Meng","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124317_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(24)02551-0","article-title":"Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study","volume":"405","author":"Sangro","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2026.124317_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102848","article-title":"Local administration of immunotherapy for patients with skin cancer: a systematic review","volume":"131","author":"Janssen","year":"2024","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.biomaterials.2026.124317_bib24","article-title":"Micro-nanomaterials-engineered delivery systems for reshaping the tumor immune microenvironment in hepatocellular carcinoma","author":"Miao","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124317_bib25","first-page":"590","article-title":"Risk of bleeding in hepatocellular carcinoma patients treated with atezolizumab\/bevacizumab: a systematic review and meta-analysis","volume":"13","author":"Song","year":"2024","journal-title":"Liver Cancer"},{"key":"10.1016\/j.biomaterials.2026.124317_bib26","article-title":"Carrier-free methylene blue nanomedicine for prolonged hepatic visualization in anatomical hepatectomy: a translational study from bench to bedside","volume":"520","author":"Chen","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2026.124317_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146061","article-title":"Carrier-free 5-Fu nanoparticle-mediated domestication therapy for scar treatment: a preclinical and first-in-human study","volume":"475","author":"He","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124317_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001435","article-title":"Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma","volume":"8","author":"Shigeta","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124317_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121302","article-title":"Imiquimod-gemcitabine nanoparticles harness immune cells to suppress breast cancer","volume":"280","author":"Singh","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124317_bib34","article-title":"Transarterial chemoembolization combined with lenvatinib plus PD-1 inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124317_bib35","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s00432-021-03767-4","article-title":"Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study","volume":"148","author":"Chen","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib36","article-title":"TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.945915","article-title":"Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: a propensity score matching study","volume":"12","author":"Guo","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124317_bib38","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1002\/cam4.5880","article-title":"Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: a multicenter, retrospective study","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124317_bib39","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3748\/wjg.v29.i10.1614","article-title":"Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma","volume":"29","author":"Wang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231200320","article-title":"TACE combined with lenvatinib and camrelizumab for unresectable multiple nodular and large hepatocellular carcinoma (>5 cm)","volume":"22","author":"Xiang","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.biomaterials.2026.124317_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221133640","article-title":"Sorafenib, lenvatinib, or lenvatinib combining PD-1 inhibitors plus TACE in unresectable hepatocellular carcinoma: a retrospective analysis","volume":"21","author":"Zhao","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124317_bib42","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1002\/cam4.5841","article-title":"Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features","volume":"12","author":"Zou","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124317_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","article-title":"The role of angiogenesis in hepatocellular carcinoma","volume":"25","author":"Morse","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124317_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2026.124317_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102622","volume":"72","author":"Jin","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.biomaterials.2026.124317_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102234","article-title":"Fundamentals and applications of particle stabilized emulsions in cosmetic formulations","volume":"283","author":"Venkataramani","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biomaterials.2026.124317_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2019.07.003","article-title":"Pickering emulsions: preparation processes, key parameters governing their properties and potential for pharmaceutical applications","author":"Albert","year":"2019","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124317_bib45","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41551-024-01178-7","article-title":"Severely polarized extracellular acidity around tumour cells","volume":"8","author":"Feng","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124317_bib46","article-title":"pH-regulating lipiodol pickering emulsions enhance transarterial embolization therapy via inducing ferroptosis and activating antitumor immunity","volume":"7","author":"Yang","year":"2026","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad257","article-title":"Self-fueling ferroptosis-inducing microreactors based on pH-responsive lipiodol pickering emulsions enable transarterial ferro-embolization therapy","volume":"11","author":"Wang","year":"2024","journal-title":"Natl. Sci. Rev."},{"issue":"Pt 4","key":"10.1016\/j.biomaterials.2026.124317_bib48","article-title":"PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein","volume":"281","author":"Lu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124317_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.118.034165","article-title":"Antiangiogenic VEGF(165)b regulates macrophage polarization via S100A8\/S100A9 in peripheral artery disease","volume":"139","author":"Ganta","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124317_bib50","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/acsnano.3c10037","article-title":"Tumor-microenvironment-activatable nanoparticle mediating immunogene therapy and M2 macrophage-targeted inhibitor for synergistic cancer immunotherapy","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124317_bib51","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1021\/acs.jmedchem.4c00508","article-title":"Discovery of a novel CSF-1R inhibitor with highly improved pharmacokinetic profiles and superior efficacy in colorectal cancer immunotherapy","volume":"67","author":"Lv","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib53","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1038\/s41467-024-52902-5","article-title":"Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response","volume":"15","author":"Tan","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124317_bib54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2020.11.037","article-title":"CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma","volume":"74","author":"Diggs","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124317_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","article-title":"Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124317_bib56","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124317_bib57","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124317_bib58","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124317_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"8046","key":"10.1016\/j.biomaterials.2026.124317_bib60","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","article-title":"Cancer cells impair monocyte-mediated T cell stimulation to evade immunity","volume":"637","author":"Elewaut","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124317_bib61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124317_bib62","article-title":"Rhein-based pickering emulsion for hepatocellular carcinoma: shaping the metabolic signaling and immunoactivation in transarterial chemoembolization","volume":"5","author":"Liang","year":"2024","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124317_bib63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jconrel.2025.01.074","article-title":"Optimizing interventional therapy: a homogeneous lipiodol formulation of tirapazamine and sorafenib responsive to post-embolization microenvironment","volume":"379","author":"Gao","year":"2025","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124317_bib64","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2024-332371","article-title":"CD64(+) fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8(+) T cells","volume":"73","author":"Zhou","year":"2024","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124317_bib65","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.trecan.2025.04.008","article-title":"Tumor-draining lymph nodes - friend or foe during immune checkpoint therapy?","volume":"11","author":"von Renesse","year":"2025","journal-title":"Trends Cancer"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:21:21Z","timestamp":1794561681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226003418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":65,"alternative-id":["S0142961226003418"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124317","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regorafenib and R837 nanoparticle-stabilized Pickering emulsions overcome the angiogenesis-immune tolerance axis in transarterial chemoembolization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124317"}}